Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease

被引:103
作者
Vassalle, C
Botto, N
Andreassi, MG
Berti, S
Biagini, A
机构
[1] CNR, Inst Clin Physiol, Area Ric, I-56100 Pisa, Italy
[2] G Pasquinucci Hosp, CNR, Inst Clin Physiol, Massa, Italy
关键词
oxidative stress; coronary artery disease; atherogenic risk factors;
D O I
10.1097/01.mca.0000063504.13456.c3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background It is well known that free radicals contribute to endothelial dysfunction and are involved in ageing and in the pathogenesis and development of many cardiovascular diseases, such as atherosclerosis. Measurement of F(2)-isoprostanes has emerged as probably the most reliable approach to assess oxidative stress status in vivo. In particular, 8-isoprostane (8-epiPGF(2alpha)) has been indicated as a marker of antioxidant deficiency and oxidative stress of potential relevance to assess human vascular diseases. Design To provide evidence for enhanced oxidative stress in coronary artery disease (CAD). Methods Plasma levels of 8-epiPGF(2alpha) (EIA, Cayman Chemicals, Ann Arbor, Michigan, USA) were measured in 51 patients (119 females, 32 males, age: 58.7 +/- 1.6 years, mean +/- SEM). Subjects included 13 healthy control subjects (group I), and 38 patients underwent coronary angiography; 11 patients without coronary artery atherosclerotic lesions (group II), and 27 with angiographically proven CAD (group III). Results Plasma levels of 8-epiPGF(2alpha) were 123.2 +/- 9.5, 314.6 +/- 40 and 389.6 +/- 36.2 pg/ml in groups I, II and III respectively (P<0.05 and P<0.001 groups II and III versus group I, respectively). In group III, 8-epiPGF(2alpha) levels increased with the number of affected vessels (324.4 +/- 47.2 and 408.3 +/- 44.1 pg/ml for one- and multi-vessel disease, P=0.07 and P<0.001 versus control subjects, respectively). A significant difference in 8-epiPGF(2α) levels was observed between patients with and without hypertension (394.2 +/- 42.7 and 232.7 +/- 25.1 pg/ml, P<0.01, respectively). In addition, patients with dyslipidaemia presented higher 8-epiPGF(2alpha) levels with respect to non-dyslipidaemic patients (359.1 +/- 35.6 and 240.3 +/- 34.3 pg/ml, P<0.05, respectively). A positive relationship was found between age and 8-epiPGF(2α) levels (r=0.42, P<0.01) in the whole population. Conclusion These findings indicate that elevated levels of plasma 8-epiPGF(2alpha) levels are associated with the extent and the severity of coronary artery disease and with the occurrence of different atherogenic risk factors, supporting the hypothesis that the evaluation of oxidative stress may represent an additional prognostic predictor in such events and a potential target of future therapeutic interventions.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 39 条
  • [1] Aliev G, 2002, BRAIN PATHOL, V12, P21
  • [2] Andreassi MG, 2000, ENVIRON MOL MUTAGEN, V35, P265, DOI 10.1002/1098-2280(2000)35:4<265::AID-EM1>3.0.CO
  • [3] 2-M
  • [4] Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty
    Andreassi, MG
    Botto, N
    Rizza, A
    Colombo, MG
    Palmieri, C
    Berti, S
    Manfredi, S
    Masetti, S
    Clerico, A
    Biagini, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (05) : 862 - 868
  • [5] Belton O, 2000, CIRCULATION, V102, P840
  • [6] EVIDENCE FOR A MONOCLONAL ORIGIN OF HUMAN ATHEROSCLEROTIC PLAQUES
    BENDITT, EP
    BENDITT, JM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (06) : 1753 - 1756
  • [7] Elevated levels of oxidative DNA damage in patients with coronary artery disease
    Botto, N
    Masetti, S
    Petrozzi, L
    Vassalle, C
    Manfredi, S
    Biagini, A
    Andreassi, M
    [J]. CORONARY ARTERY DISEASE, 2002, 13 (05) : 269 - 274
  • [8] Large, sustained cardiac lipid peroxidation and reduced antioxidant capacity in the coronary circulation after brief episodes of myocardial ischemia
    Buffon, A
    Santini, SA
    Ramazzotti, V
    Rigattieri, S
    Liuzzo, G
    Biasucci, LM
    Crea, F
    Giardina, B
    Maseri, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) : 633 - 639
  • [9] Antioxidant responses to oxidant-mediated lung diseases
    Comhair, SAA
    Erzurum, SC
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2002, 283 (02) : L246 - L255
  • [10] Blood radicals - Reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system
    DarleyUsmar, V
    Halliwell, B
    [J]. PHARMACEUTICAL RESEARCH, 1996, 13 (05) : 649 - 662